DESCRIPTION
Amino Acid Sequence
Basic description
Utility
Amyloid β Protein Fragment 1-40 has been used:
- within the temperature based mostly conformational research utilizing Fourier rework infrared/differential scanning calorimetry (FT-IR/DSC) research
- as a reference commonplace in sandwich-type enzyme immunoassay for quantifying amyloid A4 protein in cerebrospinal fluid of sufferers with head trauma
- as a part of embryonic stem cell medium to inhibit amyloid deposition in fibroblasts
Biochem/physiol Actions
Reconstitution
Different Notes

Summary
Alzheimer’s illness (AD) pathogenesis is broadly believed to be pushed by the manufacturing and deposition of the β-amyloid peptide (Aβ). For a few years, investigators have been puzzled by the weak to nonexistent correlation between the quantity of neuritic plaque pathology within the human mind and the diploma of medical dementia. Current advances in our understanding of the event of amyloid pathology have helped resolve this thriller. Substantial proof now signifies that the solubility of Aβ, and the amount of Aβ in numerous swimming pools, could also be extra intently associated to illness state. The composition of those swimming pools of Aβ displays completely different populations of amyloid deposits, and has particular correlates with the medical standing of the affected person. Imaging applied sciences, together with new amyloid imaging brokers based mostly on the chemical construction of histologic dyes, are actually making it doable to trace amyloid pathology together with illness development within the residing affected person. Apparently, these approaches point out that the Aβ deposited in AD is completely different from that present in animal fashions. Normally, deposited Aβ is extra simply cleared from the mind in animal fashions, and doesn’t present the identical bodily and biochemical traits because the amyloid present in AD. This raises necessary points concerning the event and testing of future therapeutic brokers.
Amyloid beta Protein (33-42) |
|||
20-abx266417 | Abbexa |
|
|
Amyloid beta 1-42 Protein |
|||
abx060277-100ug | Abbexa | 100 ug | EUR 910.8 |
beta Amyloid 40 protein |
|||
30R-3013 | Fitzgerald | 500 ug | EUR 392.4 |
Description: Purified recombinant beta Amyloid 40 protein |
beta Amyloid 42 protein |
|||
30R-3014 | Fitzgerald | 500 ug | EUR 392.4 |
Description: Purified recombinant beta Amyloid 42 protein |
[Lys15]-Amyloid beta Protein (15-21) |
|||
20-abx265888 | Abbexa |
|
|
Amyloid beta Protein (25-35) amide |
|||
20-abx266281 | Abbexa |
|
|
Amyloid beta (A4) Precursor Protein |
|||
20-abx260881 | Abbexa |
|
|
Amyloid Beta (A4) Precursor Protein |
|||
PR27172 | Neuromics | 10 ug | EUR 381.6 |
Amyloid Beta A4 Protein (APP) Antibody |
|||
20-abx137437 | Abbexa |
|
|
Amyloid Beta A4 Protein (APP) Antibody |
|||
20-abx210155 | Abbexa |
|
|
Amyloid Beta A4 Protein (APP) Antibody |
|||
abx230512-100ug | Abbexa | 100 ug | EUR 577.2 |
Amyloid Beta A4 Protein (APP) Antibody |
|||
abx230513-100ug | Abbexa | 100 ug | EUR 577.2 |
Amyloid Beta A4 Protein (APP) Antibody |
|||
abx224105-100ug | Abbexa | 100 ug | EUR 493.2 |
Amyloid Beta A4 Protein (APP) Antibody |
|||
abx146535-100ug | Abbexa | 100 ug | EUR 526.8 |
Amyloid Beta A4 Protein (APP) Antibody |
|||
abx146606-100ug | Abbexa | 100 ug | EUR 526.8 |
Amyloid Beta A4 Protein (APP) Antibody |
|||
abx412477-01mg | Abbexa | 0.1 mg | EUR 644.4 |
Amyloid Beta A4 Protein (APP) Antibody |
|||
abx412509-01ml | Abbexa | 0.1 ml | EUR 844.8 |